Statistics
Publications
6
Citations
116
H-Index
6
Active since
2007
Masayuki Ejiri is an author at Aichi Medical University specializing in pharmacy, oncology, and medicine.
Publications per year
2007–2021
6
6
CD52 is a novel target for the treatment of FLT3-ITD-mutated myeloid leukemia
Sivasundaram Karnan, Ichiro Hanamura, Akinobu Ota et al. · Cell Death Discovery · 2021 · 19 citations · Full text
Life Sciences, Genetics, Oncology +14
Ikuto Tsukiyama, Masayuki Ejiri, Yoshihiro Yamamoto et al. · Journal of Gastrointestinal Cancer · 2016 · 16 citations · Full text
1–5 of 6